Month: April 2025

Wearable Devices Ltd. Announces a Warrant Inducement Transaction for $1.2 Million in Gross Proceeds Yokneam Illit, Israel, April 29, 2025 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), an award-winning pioneer in artificial intelligence (“AI”)-based wearable gesture control technology, today announced its entry into a warrant inducement agreement with an existing institutional investor of the Company for the immediate exercise of warrants to purchase up to 625,000 of its ordinary shares (the “January Warrants”), and warrants to purchase up to 205,500 of its ordinary shares (the “November Warrants”, and together with the January Warrants the “Existing Warrants”), at a reduced exercise price of $1.45 per ordinary share, for gross cash proceeds of approximately $1.2 million,...

The Extraordinary General Meeting (hereinafter – the Meeting) of AB Akola Group (hereinafter – the Company) was held on 29 April 2025.The total number of the Company’s shares is 167,170,481, and the number of shares granting voting rights is 166,566,819. The own shares in the amount of 603,662 acquired by the Company do not grant voting rights.In total 32 Company’s shareholders, who owned shares of the Company at the end of the Accounting day of the Meeting (22 April 2025), participated in the Meeting having 146,086,038 share votes, which amounted to 87.7 percent of the total number of the Company’s share votes. 31 duly filled General Voting Ballots were presented before the Meeting.The Board member and CFO of the Company Mažvydas Šileika participated in the Meeting.The quorum existed. Decisions of the Meeting: 1.    Election of the assurance...

Dovre Group Plc                         Stock Exchange Release                     April 29, 2025, at 5:45 pm DECISIONS OF THE ANNUAL GENERAL MEETING OF DOVRE GROUP PLC Dovre Group Plc’s Annual General Meeting held today on April 29, 2025, adopted the financial statements and consolidated financial statements for 2024 and discharged the members of the Board of Directors and the CEO from liability for the financial year ending on December 31, 2024. The Annual General Meeting also decided on the composition and remuneration of the Board of Directors, the election of the auditor, the authorization of the Board of Directors to decide on the repurchase of the Company’s own shares and on the issuance of shares as well as the issuance of other special rights entitling to shares. Payment of dividend The Annual General Meeting decided, in accordance...

Wix & ActiveCampaignWix and ActiveCampaign partner to empower businesses of all sizes to streamline customer engagement, marketing automation, and website management in one seamless solutionThe partnership  empowers businesses of all sizes, including multi-location brands and franchises, to streamline customer engagement, marketing automation, and website management in one seamless solution NEW YORK – Wix.com Ltd. (NASDAQ: WIX), the leading SaaS website builder platform globally1, today announced a partnership with ActiveCampaign, a leading marketing automation platform that helps small teams power big businesses in over 170 countries. This collaboration introduces an integrated solution for businesses of all sizes, franchises and multi-location businesses,  to streamline their website and marketing technology stack, simplifying...

Oslo, 29 April 2025: The Annual General Meeting of VOW ASA (the “Company“) will be held on Tuesday 20 May 2025 at 09:00 hours (CEST). The meeting will be held electronically through the general meeting portal LUMI AGM. The notice, with agenda for the General Meeting, including registration form and proxy (which will be sent to the shareholders with known addresses today, 29 April 2025) is attached to this disclosure. The notice and all other documents related to the items to be considered at the annual general meeting will be available on Vow’s web page, www.vowasa.com. Shareholders without the possibility to attend the meeting are encouraged to vote by proxy.   For more information, please contact:  Tina Tønnessen, CFO, Vow ASA Tel: +47 406 39 556 Email: tina.tonnessen@vowasa.com   About Vow ASA Vow and its subsidiaries...

The supervisory board of AS Trigon Property Development approved on 29th of April 2025 the audited annual report and profit allocation proposal for the year 2024. The supervisory board decided to present the annual report and profit allocation proposal as prepared by the management for the approval of the general meeting of shareholders. The revenues and profits remained unchanged compared to the preliminary disclosure on 20 February 2025. The original audited Annual Report 2024 document is submitted in machine-readable .xhtml format to the Nasdaq Tallinn Stock Exchange and digitally signed (Link: https://nasdaqbaltic.com/statistics/et/instrument/EE3100003443/reports). The audited Annual Report of AS Trigon Property Development for 2024 in pdf-format without European Single Electronic Format (ESEF) markups is available on issuer’s home...

An exposure-outcome analysis in 72 patients with refractory non-small cell lung cancer (NSCLC) who received AFM24 at 480 mg weekly demonstrates that higher drug exposure (above median) leads to improved objective response rate (33.3% vs 5.6%) and longer progression free survival (PFS) (7.3 mo. vs 2.9 mo.) without a negative impact on safety These findings will be incorporated in future AFM24 trials to further improve efficacy outcomes of patients treated with AFM24MANNHEIM, Germany, April 29, 2025 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today presented findings on an exposure-outcome analysis of its innate cell engager (ICE®) AFM24, in patients with advanced or metastatic non-small cell lung cancer (NSCLC)...

Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignancies VANCOUVER, British Columbia, April 29, 2025 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing next-generation cancer therapies through artificial intelligence (AI)-powered drug discovery, today announced the presentation of new preclinical data from two of its lead programs at the American Association for Cancer Research (AACR) Annual Meeting 2025. The first presentation highlighted Rakovina’s PARP1-selective inhibitor program. Using the proprietary Deep Docking and generative platforms , Rakovina previously screened more than four billion potential drug-like molecules to identify a shortlist of top candidates. These compounds were synthesized and...

Kalmar Ottawa AutoTT, an autonomous terminal tractorKalmar Ottawa AutoTT, an autonomous terminal tractor is undergoing its second round of testingOTTAWA, KANSAS, April 29, 2025 (GLOBE NEWSWIRE) — Today, Kalmar, a leader in terminal tractor solutions, and autonomous systems provider, Forterra unveiled the Kalmar Ottawa AutoTT™, an autonomous terminal tractor designed to improve efficiency and safety in distribution centers, container terminals, and industrial yards. The AutoTT™ is currently undergoing its second round of testing as Kalmar moves closer to bringing it to market, with full production anticipated by late 2026.  The partnership between Kalmar and Forterra, established in March 2024, brings together Kalmar’s expertise and leadership in terminal tractors with Forterra’s AutoDrive®, an advanced autonomous...